| pubmed-article:16600723 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C0025266 | lld:lifeskim |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C0754659 | lld:lifeskim |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C0033085 | lld:lifeskim |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C2252854 | lld:lifeskim |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:16600723 | lifeskim:mentions | umls-concept:C1554184 | lld:lifeskim |
| pubmed-article:16600723 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:16600723 | pubmed:dateCreated | 2006-4-7 | lld:pubmed |
| pubmed-article:16600723 | pubmed:abstractText | We determined whether the decrease in serum PSA seen with 5alpha-reductase inhibitors affects the clinical usefulness of PSA for prostate cancer screening using data from 2 dutasteride benign prostatic hyperplasia studies. | lld:pubmed |
| pubmed-article:16600723 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16600723 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16600723 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16600723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16600723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16600723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16600723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16600723 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16600723 | pubmed:month | May | lld:pubmed |
| pubmed-article:16600723 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:16600723 | pubmed:author | pubmed-author:RoehrbornClau... | lld:pubmed |
| pubmed-article:16600723 | pubmed:author | pubmed-author:MarbergerMich... | lld:pubmed |
| pubmed-article:16600723 | pubmed:author | pubmed-author:AndrioleGeral... | lld:pubmed |
| pubmed-article:16600723 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16600723 | pubmed:volume | 175 | lld:pubmed |
| pubmed-article:16600723 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16600723 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16600723 | pubmed:pagination | 1657-62 | lld:pubmed |
| pubmed-article:16600723 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:meshHeading | pubmed-meshheading:16600723... | lld:pubmed |
| pubmed-article:16600723 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16600723 | pubmed:articleTitle | Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride. | lld:pubmed |
| pubmed-article:16600723 | pubmed:affiliation | Division of Urologic Surgery, Washington University, St. Louis, Missouri 63110, USA. andrioleg@msnotes.wustl.edu | lld:pubmed |
| pubmed-article:16600723 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16600723 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16600723 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16600723 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16600723 | lld:pubmed |
